Patent · US Expired

Piperidine derivative and pharmaceutical composition containing the same

US4876262A · kind A · utility

15Cited by
3References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 18, 1987
Grant dateOct 24, 1989
Priority date
Expiry dateFeb 18, 2007

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D473/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A new piperidine compound is pharmacologically effective for treatment of the arrythmia and is defined by the formula: ##STR1## in which R1 is a lower alkyl or a tolyl, R2 is hydrogen, hydroxyl, a lower alkoxy or a lower alkyl, R3 is hydrogen, a lower alkyl, a lower alkenyl, a cycloalkyl or a cycloalkylalkyl, X is --CO--, --CH2-- or --CHOH--, g is an integer of 1 to 3, h is an integer of 1 to 3, Y is hydrogen, a lower alkyl, a lower alkenyl, cyano, --CH2COOR, R being hydrogen or a lower alkyl, a cycloalkyl, a cycloalkylalkyl, ##STR2## 1 being 1 or 2, --A--B, A being --(CH2)n--, n being an integer of 1 to 5, a straight-chain alkylene group having 1 to 5 carbon atoms which is a divalent group derived from a straight-chain alkane having lower alkyl, phenyl or hydroxyl group(s) bonded directly to one or more carbon atoms constituting said alkane by removing a hydrogen atom bonded to each of the carbon atoms placed at both ends thereof, PA1 a straight-chain alkylene group having 1 to 5 carbon atoms which is a divalent group derived from a straight-chain alkene having a double bond formed between carbon atoms adjacent to each other by removing a hydrogen atom bonded to each of the carbon…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.